Navigation Links
Defective HIV Testing Kits Poses Serious Health Risks

A noted India-born AIDS researcher in the US says that defective or sub-standard medical kits supplied by the government's National AIDS Control Organization (NACO) for testing HIV in different blood banks and hospitals in India has put a large number of Indians at serious health risk.

Kunal Saha, the researcher based in Columbus, Ohio, was appointed by the World Bank to investigate allegations of sub-standard HIV testing kits being distributed in India.

Now he is all set to expose the scam after having obtained permission from the bank to go public with the findings about "the bogus HIV testing kits supplied by NACO and used by hospitals across India," Saha said.

Saha and other members of the World Bank team discovered that that there was "fraud" in distribution of HIV testing kits that has put Indian patients in serious danger of contracting AIDS from contaminated blood, he said.

Saha is known for his crusade against the medical fraternity in India after his wife's death from alleged wrong treatment. He has now got a nod from Ana Palacio, senior vice-president of the World Bank, to go public with potentially damaging information about distribution of dud HIV testing kits in India.

"In a letter, the World Bank has informed me that they have no intention to restrict me from my ethical obligation (as a medical doctor) 'to safeguard public health' in India," Saha told IANS from Columbus Friday.

"The obligations imposed by the confidentiality agreement are intended to preclude improper disclosure of information obtained in the course of your work; however, they are not intended to restrict your ability to comply with your ethical obligations as a medical doctor to safeguard public health," Palacio wrote.

"I am extremely happy that the World Bank has finally agreed to give me the green signal to go ahead with my findings."

A team from the Department of I nstitutional Integrity (INT) of the World Bank came to India in March-April 2007 to investigate allegations of corruption in the distribution of HIV testing kits in different parts of India. Saha came with the World Bank team as a medical consultant from the US.

Two other doctors from India were also in the World Bank team, which visited a number of hospitals and blood banks across India, including several major centres in New Delhi, Mumbai and Bangalore. The final World Bank report is yet to be released formally.

World Bank funds a substantial portion of India's battle against HIV/AIDS.

Upon his return to the US, Saha wrote to Paul Wolfowitz, then president of the World Bank, about the discovery by the team.

"Since I was under a 'confidentiality agreement' with the World Bank, I sought special permission from Wolfowitz so that I could go public with the information about the sub-standard HIV testing kits which has jeopardised the lives of innocent patients without violating the confidentiality agreement with the Bank," Saha said.

"I plan to hold a video press conference in New Delhi from the US to come out with what we have found," Saha said.

In West Bengal, a huge dud HIV testing kit scam was exposed in October 2006, pointing fingers at senior health officials.

Monozyme India, a Secunderabad-based company, has been charged with supplying expired blood test kits in West Bengal over a period of two years. Health workers fear that thousands of people across the state might have received contaminated blood, which was tested with kits whose expiry dates had been tampered with.

Saha is known for his ongoing legal battle against several eminent Kolkata doctors for the death of his wife, Anuradha Saha, from alleged "medical negligence" when the couple came to India for a social visit in 1998.

Saha has formed "People for Better Treatment" (PB T), a humanitarian society to help the victims of medical negligence and promote better healthcare in India.


'"/>




Related medicine news :

1. Defective heart valve causes problems
2. Defective ATM Gene Increases the Risk of Breast Cancer
3. Can Defective Babies Be Made To Order?
4. Defective Defibrillators
5. Defective Defibrillators
6. First Vaccine Designed for Africa Cleared for Testing in Humans
7. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
8. Testing for blood sugar levels made easier
9. DNA Testing For More Accurate Results
10. SARS vaccine shows promise in Animal Testing
11. Testing Of Saliva May Predict Dental Caries
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... ... specializing in medical device compliance and commercialization, has just released a new ... , FDA is more adamant than ever about medical device, pharmaceutical, and ...
(Date:9/20/2017)... ... September 20, 2017 , ... As part of The Garland ... a redesigned website. The new site – still located at http://www.garlandco.com ... and other industry users that Garland serves. , After an ambitious phase of ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... digital and social campaign, “Humans With Vaginas.” The goal is to ignite conversation ... of non-toxic personal care products. The brand has declared September “Humans with Vaginas” ...
(Date:9/20/2017)... ... 20, 2017 , ... Health & Safety Institute (HSI) is offering discounted pricing ... 40-Hour courses from now until November 30, 2017 to assist with the clean-up efforts ... to all businesses and government agencies – whether or not they will be directly ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the exciting story of ... life. This mouse sets out on a journey that will show that friends are ... creation of newly published author and illustrator, Melody Gersonde-Mickelson, who has earned a bachelor’s ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
Breaking Medicine Technology: